{
    "eid": "2-s2.0-85128028897",
    "title": "The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments",
    "cover-date": "2022-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [],
    "authors": [
        "Abbas F. Almulla",
        "Asara Vasupanrajit",
        "Chavit Tunvirachaisakul",
        "Hussein K. Al-Hakeim",
        "Marco Solmi",
        "Robert Verkerk",
        "Michael Maes"
    ],
    "citedby-count": 21,
    "ref-count": 129,
    "ref-list": [
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
        "Immunological characteristics of schizophrenia",
        "The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study",
        "Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways",
        "Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse",
        "Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "New drug targets in depression: Inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates\u2014Nrf2 activators and GSK-3 inhibitors",
        "The new \u20185-HT\u2019 hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression\u2014and other conditions characterized by tryptophan depletion induced by inflammation",
        "The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: Role of hemeoxygenase-1",
        "Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder",
        "Relationships between plasma, CSF and brain tryptophan",
        "Correlation between brain tryptophan and plasma neutral amino acid levels following food consumption in rats",
        "Blood-brain barrier transport of kynurenines: Implications for brain synthesis and metabolism",
        "Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency",
        "Kynurenine metabolism in central nervous system in experimental chronic renal failure",
        "Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain",
        "L-kynurenine: Its synthesis and possible regulatory function in brain",
        "Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia",
        "Increased cortical kynurenate content in schizophrenia",
        "Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia",
        "Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system",
        "The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression",
        "Kynurenic acid in schizophrenia: a systematic review and meta-analysis",
        "Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis",
        "Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis",
        "The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies",
        "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",
        "Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia",
        "Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range",
        "Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression",
        "Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: A systematic review and meta-analysis",
        "Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis",
        "Serum kynurenic acid is reduced in affective psychosis",
        "Correlations of kynurenic Acid, 3-hydroxykynurenine, sIL-2R, IFN-alpha, and IL-4 with clinical symptoms during acute relapse of schizophrenia",
        "Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2212significance for activation of the kynurenine pathway",
        "Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia",
        "Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients",
        "Increased plasma kynurenic acid levels are associated with impaired attention/vigilance and social cognition in patients with schizophrenia",
        "Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia",
        "Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls",
        "Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia",
        "Immune and neuroendocrine trait and state markers in psychotic illness: Decreased kynurenines marking psychotic exacerbations",
        "Tryptophan metabolism and white matter integrity in schizophrenia",
        "Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia",
        "Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder",
        "Kynurenine pathway in psychosis: evidence of increased tryptophan degradation",
        "Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case-control study",
        "Is plasma serine a marker for psychosis?",
        "3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia",
        "Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis",
        "Xanthurenic acid activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia",
        "Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients",
        "Kynurenine is correlated with IL-1beta in plasma of schizophrenia patients",
        "Imbalanced kynurenine pathway in schizophrenia",
        "Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients",
        "Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration",
        "Profiling of amino acids and their derivatives biogenic amines before and after antipsychotic treatment in first-episode psychosis",
        "Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients",
        "Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome",
        "Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects",
        "Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders",
        "Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine",
        "Amino acids in schizophrenia: Evidence for lower tryptophan availability during treatment with atypical antipsychotics?",
        "Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls",
        "Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia",
        "Relationship between kynurenine pathway metabolites and cognitive function in schizophrenia patients",
        "Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset",
        "Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia",
        "Determination and clinical significance of serum kynurenine and kynurenic acid levels in schizophrenia %",
        "Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders",
        "Immunologic alterations in schizophrenia: neopterin, L-kynurenine, tryptophan and T-cell subsets in the acute stage of illness",
        "Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia",
        "Acid: a potential biomarker and treatment target for schizophrenia",
        "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1beta levels in patients with schizophrenia spectrum disorder and their siblings",
        "Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites",
        "Low plasma tryptophan levels in recently hospitalized schizophrenics",
        "A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study",
        "Peripheral cortisol and inflammatory response to a psychosocial stressor in people with schizophrenia",
        "Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers",
        "An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation",
        "Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia",
        "Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia",
        "Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms",
        "Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder",
        "Determination of kynurenic acid and tryptophan in serum by high performance liquid chromatography with fluorescence detection %",
        "Simultaneous determination of amino acids and neurotransmitters in plasma samples from schizophrenic patients by hydrophilic interaction liquid chromatography with tandem mass spectrometry",
        "Determination and clinical significance of serum kynurenine and kynurenine 3 -monooxygenase levels in schizophrenia",
        "Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia",
        "Associations between the kynurenine pathway, proinflammatory cytokines, and brain-derived neurotrophic factor in hospitalized patients with chronic schizophrenia: a preliminary study",
        "How immune-inflammatory processes link CNS and psychiatric disorders: classification and treatment implications",
        "Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: role of the aryl hydrocarbon receptor and direct mitochondria regulation",
        "deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity",
        "Kynurenines in the mammalian brain: when physiology meets pathology",
        "Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases",
        "Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection",
        "(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats",
        "On the biological importance of the 3-hydroxyanthranilic acid: Anthranilic acid ratio",
        "Characterization of the kynurenine pathway in human neurons",
        "Kynurenic acid: The janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions",
        "Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder",
        "Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid",
        "Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode schizophrenia",
        "A comparison of serum and plasma blood collection tubes for the integration of epidemiological and metabolomics data",
        "EDTA in vacutainer tubes can interfere with plasma amino acid analysis",
        "Reactivity and degradation products of tryptophan in solution and proteins",
        "Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs",
        "Effects of contamination of blood specimens with liquid potassium-EDTA anticoagulant",
        "The analysis of free tryptophan in human blood with the Ultrafiltrator: a comparison with other methods",
        "Characteristics of tryptophan binding in the serum of the newborn rat",
        "Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia",
        "Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations",
        "Indole-albumin association: a comparative study",
        "Transport of tryptophan into brain from the circulating, albumin-bound pool in rats and in rabbits",
        "Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients",
        "Multivariate analysis of structural and functional neuroimaging can inform psychiatric differential diagnosis",
        "Cross-validation of functional MRI and paranoid-depressive scale: results from multivariate analysis",
        "Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3"
    ],
    "affiliation": [
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Ottawa",
            "@id": "60085927",
            "affilname": "L'H\u00f4pital d'Ottawa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60085927",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Ottawa",
            "@id": "60028897",
            "affilname": "University of Ottawa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028897",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Antwerpen",
            "@id": "60012937",
            "affilname": "Universiteit Antwerpen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012937",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ottawa",
            "@id": "60002173",
            "affilname": "Ottawa Hospital Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002173",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}